XIAOMI-W
01810
MEITUAN-W
03690
TME-SW
01698
BABA-W
09988
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 75.58%46.16M | 218.13%44.04M | 183.88%26.29M | -448.26%-37.28M | -156.49%-31.34M | -93.61%10.7M | -68.99%55.48M | -46.68%167.58M | 26.08%178.9M | 16.02%314.32M |
Operating income | 75.58%46.16M | 218.13%44.04M | 183.88%26.29M | -448.26%-37.28M | -156.49%-31.34M | -93.61%10.7M | -68.99%55.48M | -46.68%167.58M | 26.08%178.9M | 16.02%314.32M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -22,937.08%-20.5M | ---5.29M |
Employee expense | -23.64%-7.96M | -21.93%-27.3M | 50.67%-6.44M | 53.36%-22.39M | 47.82%-13.05M | 48.74%-48M | 77.23%-25.01M | 63.24%-93.64M | 10.81%-109.82M | -6.98%-254.73M |
Depreciation and amortization | 27.59%-1.07M | 80.49%-1.79M | 69.87%-1.48M | 39.33%-9.19M | 38.89%-4.91M | 18.96%-15.15M | 44.97%-8.03M | 50.43%-18.69M | 24.53%-14.59M | -252.28%-37.72M |
Impairment and provision | ---- | -954.70%-2M | ---- | 109.34%234K | ---- | 89.85%-2.51M | ---- | -248.83%-24.7M | ---20.75M | 28.03%-7.08M |
-Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | 87.92%-2.51M | ---- | -201.70%-20.75M | ---20.75M | 31.77%-6.88M |
-Other impairment is provision | ---- | -954.70%-2M | ---- | --234K | ---- | ---- | ---- | -1,837.25%-3.95M | ---- | -185.00%-204K |
Special items of operating profit | -30.20%12.76M | 406.07%34.45M | 312.98%18.28M | -505.48%-11.26M | 18.56%-8.59M | 111.08%2.78M | 63.48%-10.54M | 56.58%-25.04M | -47.29%-28.87M | -42.47%-57.68M |
Operating profit | 36.11%49.89M | 159.33%47.4M | 163.33%36.66M | -53.10%-79.88M | -586.33%-57.88M | -1,047.79%-52.18M | 176.12%11.9M | 111.43%5.51M | 22.83%-15.64M | -70.66%-48.18M |
Financing income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.79%8.65M | ---- | 163.51%6.88M |
Financing cost | -31.21%-227K | 87.75%-218K | 89.46%-173K | 71.44%-1.78M | 46.46%-1.64M | 3.62%-6.23M | -2.03%-3.07M | -43.36%-6.47M | -103.66%-3.01M | -8,253.70%-4.51M |
Earning before tax | 36.13%49.67M | 157.77%47.18M | 161.29%36.49M | -39.81%-81.66M | -773.74%-59.53M | -859.94%-58.41M | 147.40%8.84M | 116.77%7.69M | 2.11%-18.64M | -78.43%-45.82M |
Tax | -2,981.25%-1.97M | -226.21%-785K | 93.15%-64K | -78.63%622K | -193.21%-934K | -65.67%2.91M | -84.26%1M | 21.72%8.48M | 86.06%6.37M | 929.40%6.97M |
After-tax profit from continuing operations | 30.95%47.7M | 157.25%46.39M | 160.24%36.42M | -46.02%-81.04M | -714.61%-60.46M | -443.30%-55.5M | 180.15%9.84M | 141.61%16.17M | 21.43%-12.27M | -46.51%-38.85M |
After-tax profit from non-continuing business | ---- | ---- | ---- | 489.52%47.64M | 962.45%47.64M | -1,224.17%-12.23M | ---5.52M | --1.09M | ---- | ---- |
Earning after tax | 30.95%47.7M | 238.91%46.39M | 384.16%36.42M | 50.69%-33.4M | -397.17%-12.82M | -492.54%-67.73M | 135.14%4.31M | 144.41%17.25M | 21.43%-12.27M | -152.23%-38.85M |
Profit attributable to shareholders | 30.95%47.7M | 238.91%46.39M | 384.16%36.42M | 50.69%-33.4M | -397.17%-12.82M | -492.54%-67.73M | 135.14%4.31M | 144.41%17.25M | 21.43%-12.27M | -150.82%-38.85M |
Basic earnings per share | 25.00%0.004 | 237.93%0.004 | 390.91%0.0032 | 51.67%-0.0029 | -375.00%-0.0011 | -500.00%-0.006 | 136.36%0.0004 | 144.12%0.0015 | 0.00%-0.0011 | -141.46%-0.0034 |
Diluted earnings per share | 25.00%0.004 | 237.93%0.004 | 390.91%0.0032 | 51.67%-0.0029 | -375.00%-0.0011 | -500.00%-0.006 | 136.36%0.0004 | 144.12%0.0015 | 0.00%-0.0011 | -141.46%-0.0034 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.